Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Abbott Medical Devices
- Study ID
- NCT03876054
- Status
- Recruiting
Conditions
- Chronic Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spinal cord stimulation (SCS) — DEVICESubjects will be implanted with market-released Abbott SCS systems
- Dorsal root ganglion stimulation (DRG) — DEVICESubjects will be implanted with market-released Abbott DRG system
Study Details
The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
Key Dates
- Start date
- Mar 13, 2019
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Spinal cord stimulation (SCS)Subjects using Abbott SCS systems
- Arm: Dorsal root ganglion stimulation (DRG)Subjects using Abbott DRG system
Primary Outcome Measure
Rate of device and procedure related adverse events, deaths, and device deficiencies [ Time Frame: Baseline ]
Central Contacts
- Bram Blomme+32 474 74 83 10
- Sonar Pradhan+1 818-282-6456
Locations (30)
Find similar trials in Phoenix, AZ
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory TestingRecruiting · Anna Evans Phillips · Baltimore, Maryland
- Optimization of NIBS for Treatment of AddictionRecruiting · Case Western Reserve University · Hinsdale, Illinois
- Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS ActivityPHASE2 · Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina